ConductScience.org, home

Paper41300302

The Roles of Sirt1 in Breast and Gynecologic Malignancies.

Ding J and 2 others. Biology (Basel), 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. The Roles of Sirt1 in Breast and Gynecologic Malignancies. Papers, record 41300302. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41300302

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Roles of Sirt1 in Breast and Gynecologic Malignancies.
PubMed
Journal
Biology (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.47, provisional
iCite
Revised in PubMed
2025-11-30
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ding JJianmin
2Ye MTMatthew Thttps://orcid.org/0000-0002-1397-0968
3Zhang SSonglinhttps://orcid.org/0009-0004-3811-2099

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
N/AInternal fundingPubMed
N/AInternal fundingPubMed

Source PubMed

Download CSV of grants

References190

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122888282The genomics and genetics of endometrial cancer.Adv Genomics Genet2012https://conductscience.org/library/papers/22888282PubMed
230181620FR58P1a; a new uncoupler of OXPHOS that inhibits migration in triple-negative breast cancer cells via Sirt1/AMPK/β1-integrin pathway.Sci Rep2018https://conductscience.org/library/papers/30181620PubMed
325223731An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease.Br J Clin Pharmacol2015https://conductscience.org/library/papers/25223731PubMed
426004371Distinctive role of SIRT1 expression on tumor invasion and metastasis in breast cancer by molecular subtype.Hum Pathol2015https://conductscience.org/library/papers/26004371PubMed
530982660Loss of Sirtuin 1 Alters the Secretome of Breast Cancer Cells by Impairing Lysosomal Integrity.Dev Cell2019https://conductscience.org/library/papers/30982660PubMed
634808628Silent Information Regulator 1 Promotes Proliferation, Migration, and Invasion of Cervical Cancer Cells and Is Upregulated by Human Papillomavirus 16 E7 Oncoprotein.Gynecol Obstet Invest2022https://conductscience.org/library/papers/34808628PubMed
733438275Sirtuin 1 promotes autophagy and proliferation of endometrial cancer cells by reducing acetylation level of LC3.Cell Biol Int2021https://conductscience.org/library/papers/33438275PubMed
835252293Molecular Mechanism Underlying the Regulatory Effect of Vine Tea on Metabolic Syndrome by Targeting Redox Balance and Gut Microbiota.Front Nutr2022https://conductscience.org/library/papers/35252293PubMed
932902187Histone H3K9 and H3K14 acetylation at the promoter of the LGALS9 gene is associated with mRNA levels in cervical cancer cells.FEBS Open Bio2020https://conductscience.org/library/papers/32902187PubMed
1036690678NAD+ supplementation limits triple-negative breast cancer metastasis via SIRT1-P66Shc signaling.Oncogene2023https://conductscience.org/library/papers/36690678PubMed
1122017869Peptide switch is essential for Sirt1 deacetylase activity.Mol Cell2011https://conductscience.org/library/papers/22017869PubMed
126822361Two pathogenetic types of endometrial carcinoma.Gynecol Oncol1983https://conductscience.org/library/papers/6822361PubMed
1336830834The Adipokine Visfatin Modulates Cancer Stem Cell Properties in Triple-Negative Breast Cancer.Biomedicines2023https://conductscience.org/library/papers/36830834PubMed
1430217020A New Synthetic Histone Deacetylase Inhibitor, MHY2256, Induces Apoptosis and Autophagy Cell Death in Endometrial Cancer Cells via p53 Acetylation.Int J Mol Sci2018https://conductscience.org/library/papers/30217020PubMed
1529992272A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects.Am J Clin Nutr2018https://conductscience.org/library/papers/29992272PubMed
1628498637β2-AR activation induces chemoresistance by modulating p53 acetylation through upregulating Sirt1 in cervical cancer cells.Cancer Sci2017https://conductscience.org/library/papers/28498637PubMed
1723169992SIRT1 represses estrogen-signaling, ligand-independent ERα-mediated transcription, and cell proliferation in estrogen-responsive breast cells.J Endocrinol2013https://conductscience.org/library/papers/23169992PubMed
1833649834SIRT1 and gynecological malignancies (Review).Oncol Rep2021https://conductscience.org/library/papers/33649834PubMed
1922661383Expression of SIRT1 is associated with lymph node metastasis and poor prognosis in both operable triple-negative and non-triple-negative breast cancer.Med Oncol2012https://conductscience.org/library/papers/22661383PubMed
2019595309Sirtuins and p53.Adv Cancer Res2009https://conductscience.org/library/papers/19595309PubMed

See all 190 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42883867Targeting Aromatase and HDACs in Hormone Receptor-Positive Breast Cancer: Molecular Interplay, Endocrine Resistance and Therapeutic Opportunities.Int J Mol Sci2026https://conductscience.org/library/papers/42883867PubMed
42794654SIRT1 Promotes Breast Cancer Stem Cell-Associated Properties and Represents a Potential Therapeutic Target.Int J Mol Sci2026https://conductscience.org/library/papers/42794654PubMed
42577302Gut microbiota-derived butyrate and the SIRT1/FoxO1 axis: epigenetic-metabolic regulation of ovarian function in premature ovarian insufficiency-a comprehensive review.Front Microbiol2026https://conductscience.org/library/papers/42577302PubMed
42212122Post-translational modifications in retinoblastoma: mechanisms, immune regulation, and therapeutic opportunities.Front Immunol2026https://conductscience.org/library/papers/42212122PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FOXO12308PubTator's text mininghttps://conductscience.org/library/genes/2308NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
SIRT123411PubTator's text mininghttps://conductscience.org/library/genes/23411NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41300302

GET https://conductscience.org/api/papers/v1/41300302/references?page=2